of the Dept. of Immunotechnology won a “Best Abstract Presentation Price” at the Oral Abstract session entitled
Risk factors and biomarkers in occupational allergy
Andy’s contribution was entitled
Prediction of chemical respiratory sensitizers using GARD, a novel in vitro assay based on a genomic biomarker signature
Andy Forreryd is a researcher at the Dept. of Immunotechnology at Lund University and a contributor to the R&D team connected to SenzaGen who’s research is the foundation for the GARD test products.
SenzaGen congratulates Andy and we are very proud to see that his great achievements as a researcher is getting acknowledged.